Please use this identifier to cite or link to this item:
|Title:||Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.|
|Authors:||Mackin, Kate E;Elliott, Briony;Kotsanas, Despina;Howden, Benjamin P;Carter, Glen P;Korman, Tony M;Riley, Thomas V;Rood, Julian I;Jenkin, Grant A;Lyras, Dena|
|Affiliation:||School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia.|
Department of Microbiology, Austin Health, Heidelberg, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, VIC, Australia.
Monash Infectious Diseases, Monash Health, Clayton, VIC, Australia; Department of Microbiology, Monash Health, Clayton, VIC, Australia.
School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia; PathWest Laboratory Medicine, Nedlands, WA, Australia.
Department of Microbiology, Monash University, Clayton, VIC, Australia.
Monash Infectious Diseases, Monash Health, Clayton, VIC, Australia.
Department of Microbiology, Monash University, Clayton, VIC, Australia. Electronic address: email@example.com.
|Citation:||Anaerobe 2015; 34(): 80-3|
|Abstract:||Some Australian strain types of Clostridium difficile appear unique, highlighting the global diversity of this bacterium. We examined recent and historic local isolates, finding predominantly toxinotype 0 strains, but also toxinotypes V and VIII. All isolates tested were susceptible to vancomycin and metronidazole, while moxifloxacin resistance was only detected in recent strains.|
|Internal ID Number:||25944720|
Clostridium difficile Australia
Clostridium difficile antibiotic resistance
Clostridium difficile epidemiology
Clostridium difficile toxinotypes
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.